Orphan Drugs Market

Orphan Drugs Market By Drug Type Biologics and Non-Biologics, ,By Sale Generics and Branded , By Therapy Class Oncology, Respiratory, Cardiovascular, Endocrine, CNS and Others :Market Research Report 2021 Covid 19 Impact Outlook, Regional Analysis, Competitive Landscape, Growth Prospects & Forecast -2026

Orphan Drugs Market

Orphan Drugs Market By Drug Type Biologics and Non-Biologics, ,By Sale Generics and Branded , By Therapy Class Oncology, Respiratory, Cardiovascular, Endocrine, CNS and Others :Market Research Report 2021 Covid 19 Impact Outlook, Regional Analysis, Competitive Landscape, Growth Prospects & Forecast -2026

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Global Orphan Drugs Market 2020 By Drug Type [Biologics and Non-Biologics,],By Sale [Generics and Branded], By Therapy Class[Oncology, Respiratory, Cardiovascular, Endocrine, CNS and Others]:Global Forecast to 2026 and COVID-19 Impact Outlook

Global Orphan Drugs Market is valued at 162.40 USD Billion in 2019 and expected to reach USD 307.64 Billion by 2026 with the CAGR of 9.5% over the forecast period.

Scope of the report

This report analyses the global market for Orphan Drugs. The report will enable the user to understand and gain insights into the current and forecast market situation. The market is comprehensively analyzed by geography to give complete information on the global scenario. The qualitative and quantitative data provided in this study can help user understand which market segments, regions are expected to grow at higher rates, factors affecting the market and key opportunity areas. The report also includes competitive landscape of key players in the industry along with emerging trends in the market.

Key Players

AbbVie, Inc.,GlaxoSmithKline PLC,F. Hoffmann-La Roche AG,Pfizer Inc.,Mylan Celgene Corporation,Vertex Pharmaceuticals Inc.,Novartis AG,Biogen,Bristol Meyer Squibb.,Takeda Pharmaceutical Company Limited,Merck KGaA,Alexion Pharmaceuticals Inc.,Janssen Global Services LLC,Eli Lilly and Company,Shire Pharmaceutical,Sanofi and others

Above mentioned companies were scrutinized to assess competitive landscape of global Orphan Drugs market. Report provides company profiles of each player. Each profile include company product portfolio,business overview, company governance, company financials, business strategies, manufacturing locations and production facilities, company sale, recent developments and strategic collaborations & partnerships, new product launch, company segments, application diversification and company strength and weakness analysis.

Review period: (2016-2026)

Historic Period: 2016 to 2019

Forecast Period: 2020 to 2026

Base Year: 2019

Unit: USD Billion

This Orphan Drugs market report provides insights on new trade regulations, import export analysis, industry value chain analysis, market size, consumption, production analysis, capacity analysis, regional and segment market share, product launches, product pipeline analysis, impact of Covid-19 on supply chain, key regions, untapped markets, patent analysis, product approvals, continuous innovations and developments in the market.

Regions

• North America: U.S., Canada and Rest of North America

• Europe: UK, France, Germany, Italy, Spain and Rest of Europe

• Asia Pacific: China, Japan, India, Australia, Southeast Asia and Rest of Asia Pacific

• Latin America: Brazil, Mexico, Argentina and Rest of Latin America

• Middle East and Africa: Gulf Countries, Israel, Africa and Rest of Middle East and Africa

Market Segmentation

• Drug Type

o Biologics

o Non-Biologics

• Sale

o Generics

o Branded

• Therapy Class

o Oncology

o Respiratory

o Cardiovascular

o Endocrine

o CNS

o Others

Report Coverage

• An overview of the global Orphan Drugs market

• In depth analysis of market dynamics and major factors such as drivers, restraints, opportunities and trends influencing the global market

• Global Orphan Drugs market revenue data historic and forecast analysis (2016 to 2026)

• Characterization and quantification of the market segments for Orphan Drugs market

• Market share analysis of key market participants and their competitive landscape

Important Questions Answered by Global Orphan Drugs Market Report

• What is the impact of COVID 19 epidemic on the global Orphan Drugs market

• Which is mostly affected region, country

• Which is the current largest and fastest-growing region

• What is the market size and growth rate of the global Orphan Drugs market

• What are current factors affecting the growth of market

• What are Key trends and opportunity areas

• Within Orphan Drugs market, which segments are fastest growing & emerging strongly What are the drivers and restraints for each segment What are vendor competencies by segment

• What are the major strategies adopted by leading market companies

• What are company challenges and essential success factors by marketsegment

• How company offerings and supply chain capabilitiesare shifting to meetemerging market needs

1. Introduction

1.1. Report Description

1.2. Market Segmentation

1.3. Research Methodology

1.4. List of Abbreviations

2. Executive Summary

3. Market Overview

3.1. Market Definition

3.2. Market Scope

3.3. Market Drivers

3.4. Market Restraints

3.5. Market Opportunities and Trends

3.6. Porter’s five force analysis

3.7. SWOT Analysis

3.8. PEST Analysis

3.9. Patent Analysis

3.10. Impact of COVID 19 on Global Orphan Drugs Market

4. Orphan Drugs Market, By Drug Type, Market Size and Forecast 2016 -2026 (USD Billion)

4.1. Global Orphan Drugs Market By Drug Type, 2016 -2026 (USD Billion)

4.1.1. Global Orphan Drugs Market By Biologics

4.1.2. Global Orphan Drugs Market By Non-Biologics

4.2. Global Orphan Drugs Market By Drug Type Share, 2016 -2026 (%)

5. Orphan Drugs Market, By Therapy Class, Market Size and Forecast 2016 -2026 (USD Billion)

5.1. Global Orphan Drugs Market By Therapy Class, 2016 -2026 (USD Billion)

5.1.1. Global Orphan Drugs Market By Oncology

5.1.2. Global Orphan Drugs Market By Respiratory

5.1.3. Global Orphan Drugs Market By Cardiovascular

5.1.4. Global Orphan Drugs Market By Endocrine

5.1.5. Global Orphan Drugs Market By CNS

5.1.6. Global Orphan Drugs Market By Others

5.2. Global Orphan Drugs Market By Therapy Class Share, 2016 -2026 (%)

6. Orphan Drugs Market, By Sale, Market Size and Forecast 2016 -2026 (USD Billion)

6.1. Global Orphan Drugs Market By Sale, 2016 -2026 (USD Billion)

6.1.1. Global Orphan Drugs Market By Generics

6.1.2. Global Orphan Drugs Market By Branded

6.2. Global Orphan Drugs Market By Sale Share, 2016 -2026 (%)

7. Orphan Drugs Market, By Region Market Size and Forecast 2016 -2026

7.1. NORTH AMERICA

7.1.1. Key Findings

7.1.2. Impact of COVID 19

7.1.3. Key market trends, growth factors and opportunities

7.1.4. North America Orphan Drugs Market by Country 2016 -2026 (USD Billion)

7.1.5. North America Orphan Drugs Market By Drug Type 2016 -2026 (USD Billion)

7.1.6. North America Orphan Drugs Market By Sale 2016 -2026 (USD Billion)

7.1.7. North America Orphan Drugs Market By Therapy Class 2016 -2026 (USD Billion)

7.2. EUROPE

7.2.1. Key Findings

7.2.2. Impact of COVID 19

7.2.3. Key market trends, growth factors and opportunities

7.2.4. Europe Orphan Drugs Market by Country 2016 -2026 (USD Billion)

7.2.5. Europe Orphan Drugs Market By Drug Type 2016 -2026 (USD Billion)

7.2.6. Europe Orphan Drugs Market By Sale 2016 -2026 (USD Billion)

7.2.7. Europe Orphan Drugs Market By Therapy Class 2016 -2026 (USD Billion)

7.3. ASIA PACIFIC

7.3.1. Key Findings

7.3.2. Impact of COVID 19

7.3.3. Key market trends, growth factors and opportunities

7.3.4. Asia Pacific Orphan Drugs Market by Country 2016 -2026 (USD Billion)

7.3.5. Asia Pacific Orphan Drugs Market By Drug Type 2016 -2026 (USD Billion)

7.3.6. Asia Pacific Orphan Drugs Market By Sale 2016 -2026 (USD Billion)

7.3.7. Asia Pacific Orphan Drugs Market By Therapy Class 2016 -2026 (USD Billion)

7.4. LATIN AMERICA

7.4.1. Key Findings

7.4.2. Impact of COVID 19

7.4.3. Key market trends, growth factors and opportunities

7.4.4. Latin America Orphan Drugs Market by Country 2016 -2026 (USD Billion)

7.4.5. Latin America Orphan Drugs Market By Drug Type 2016 -2026 (USD Billion)

7.4.6. Latin America Orphan Drugs Market By Sale 2016 -2026 (USD Billion)

7.4.7. Latin America Orphan Drugs Market By Therapy Class 2016 -2026 (USD Billion)

7.5. MIDDLE EAST AND AFRICA

7.5.1. Key Findings

7.5.2. Impact of COVID 19

7.5.3. Key market trends, growth factors and opportunities

7.5.4. Middle East and Africa Orphan Drugs Market by Country 2016 -2026 (USD Billion)

7.5.5. Middle East and Africa Orphan Drugs Market By Drug Type 2016 -2026 (USD Billion)

7.5.6. Middle East and Africa Orphan Drugs Market By Sale 2016 -2026 (USD Billion)

7.5.7. Middle East and Africa Orphan Drugs Market By Therapy Class 2016 -2026 (USD Billion)

8. Competitive Landscape Analysis

8.1. Global Orphan Drugs Market Company Revenue, (USD Billion), 2016-2019

8.2. Global Orphan Drugs Market Company Share, (%), 2016-2019

9. Company Profiles

9.1. AbbVie, Inc.

9.2. GlaxoSmithKline PLC

9.3. F. Hoffmann-La Roche AG

9.4. Pfizer Inc.

9.5. Mylan Celgene Corporation

9.6. Vertex Pharmaceuticals Inc.

9.7. Novartis AG

9.8. Biogen

9.9. Bristol Meyer Squibb.

9.10. Takeda Pharmaceutical Company Limited

9.11. Merck KGaA

9.12. Alexion Pharmaceuticals Inc.

9.13. Janssen Global Services LLC

9.14. Eli Lilly and Company

9.15. Shire Pharmaceutical

9.16. Sanofi

9.17. Others

10. Appendix

11. List of Tables

12. List of Figures

Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Orphan Drugs Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
What is the market share of the Orphan Drugs Market?
The Global Orphan Drugs Market share by vendor, as well as the concentration rate using the CR4, CR8 Index, determine the strength of competitive players like AbbVie, Inc., GlaxoSmithKline PLC, F. Hoffmann-La Roche AG, Pfizer Inc., Mylan Celgene Corporation, Vertex Pharmaceuticals Inc., Novartis AG, Biogen, Bristol Meyer Squibb., Takeda Pharmaceutical Company Limited, Merck KGaA, Alexion Pharmaceuticals Inc., Janssen Global Services LLC, Eli Lilly and Company, Shire Pharmaceutical, Sanofi.
What is the major concern of the players in the Orphan Drugs Market?
As manufacturers prepare to scale up, Orphan Drugs companies must be clear and transparent about the impact of such volatility on the balance sheet.
What are the major applications for Orphan Drugs?
Orphan Drugs has a wide range of applications, including and others.
What is the anticipated growth rate for the Orphan Drugs Market?
During the projected year from 2025 to 2030, the Orphan Drugs Market is expected to grow at a CAGR of xx%.
What challenges does the Orphan Drugs Market face in the future?
The convergence of various vital triggers, including a major slowdown in Western economies, and some critical points in globalization, leads to the transformation of business in the Orphan Drugs Market across the extensive corporate landscape.
How is the Orphan Drugs Market's changing dynamics captured?
The Orphan Drugs analysis provides high-level qualitative commentary on market dynamics, including information on growth drivers, influential trends, challenges, and opportunities.